x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Empowered Patient Podcast

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

health & fitness medicine

All Episodes

0:00

Democratizing Molecular Diagnostics Transforming...

Empowered Patient Podcast ·

2025/08/20

Andrea James, Chief Financial Officer at iMDx, is focused on expanding access to innovative molecular diagnostic testing staring with a test for monitoring transplanted organ health. The test measures the donor-derived cell-free DNA which can indicate the need for drugs to target organ rejection before invasive procedures are required. The company is developing a kit-based version of the test that can be run by hospitals rather than relying on centralized labs, to increase access to this

en

22:02

Democratizing Molecular Diagnostics Transforming...

Empowered Patient Podcast ·

2025/08/20

Andrea James, Chief Financial Officer at iMDx, is focused on expanding access to innovative molecular diagnostic testing staring with a test for monitoring transplanted organ health. The test measures the donor-derived cell-free DNA which can indicate the need for drugs to target organ rejection before invasive procedures are required. The company is developing a kit-based version of the test that can be run by hospitals rather than relying on centralized labs, to increase access to this

en

0:00

Healthcare Financial Recovery Driven by Focus on...

Empowered Patient Podcast ·

2025/08/19

James Hereford, President and CEO of Fairview Health Services, describes this Minnesota-based healthcare system's $600 million turnaround and the importance of focusing on people and processes, not just technology changes. Addressing staff shortages, quality of care, and patient experience led to finding a holistic approach that improved financial outcomes and changed the culture in a sustainable way. Investments have been made in community programs like food access and vaccination events,

en

21:46

Healthcare Financial Recovery Driven by Focus on...

Empowered Patient Podcast ·

2025/08/19

James Hereford, President and CEO of Fairview Health Services, describes this Minnesota-based healthcare system's $600 million turnaround and the importance of focusing on people and processes, not just technology changes. Addressing staff shortages, quality of care, and patient experience led to finding a holistic approach that improved financial outcomes and changed the culture in a sustainable way. Investments have been made in community programs like food access and vaccination events,

en

0:00

Innovative Homeostasis Focused Drugs to Treat Root...

Empowered Patient Podcast ·

2025/08/18

teve Butts, Co-Founder and CEO of Arrivo BioVentures, is a biopharmaceutical company focused on developing therapies that target the root causes of disease rather than just treating the symptoms. Their drugs treat major depressive disorder and acute pancreatitis through novel epigenetic mechanisms of action. Sex-based differences were observed in clinical trials where the drug SP-624 showed efficacy in females but not in males, which could lead to a paradigm shift in how depression is treated in

en

19:44

Innovative Homeostasis Focused Drugs to Treat Root...

Empowered Patient Podcast ·

2025/08/18

Steve Butts, Co-Founder and CEO of Arrivo BioVentures, is a biopharmaceutical company focused on developing therapies that target the root causes of disease rather than just treating the symptoms. Their drugs treat major depressive disorder and acute pancreatitis through novel epigenetic mechanisms of action. Sex-based differences were observed in clinical trials where the drug SP-624 showed efficacy in females but not in males, which could lead to a paradigm shift in how depression is treated in

en

0:00

Advancing Synthetic Data for Paradigm Shift in...

Empowered Patient Podcast ·

2025/08/14

Daniel Blumenthal, VP of Strategy at MDClone, is building synthetic data models to mimic real patient data without the need to protect the identity of individuals. This type of data is being utilized in drug discovery and development, building predictive tools and new care models, and to better understand biases in clinical trials making them more representative. AI tools play an essential role in generating and validating synthetic data as well as integrating it into various processes and

en

17:26

Advancing Synthetic Data for Paradigm Shift in...

Empowered Patient Podcast ·

2025/08/14

Daniel Blumenthal, VP of Strategy at MDClone, is building synthetic data models to mimic real patient data without the need to protect the identity of individuals. This type of data is being utilized in drug discovery and development, building predictive tools and new care models, and to better understand biases in clinical trials making them more representative. AI tools play an essential role in generating and validating synthetic data as well as integrating it into various processes and

en

0:00

Restoring Olfactory Function After Post-Viral Loss of...

Empowered Patient Podcast ·

2025/08/13

Rick Geoffrion, Founder and CEO of Cyrano Therapeutics, is developing a drug to restore olfactory function due to post-viral loss of smell and taste. As a result of COVID-19, there has been a significant increase in the number of people affected by long-term smell and taste loss, with no effective pharmaceutical options previously available. Smell loss can also be an early indicator of neurodegenerative conditions, suggesting future applications of the intranasal spray that aims to directly restore

en

17:07

Restoring Olfactory Function After Post-Viral Loss of...

Empowered Patient Podcast ·

2025/08/13

Rick Geoffrion, Founder and CEO of Cyrano Therapeutics, is developing a drug to restore olfactory function due to post-viral loss of smell and taste. As a result of COVID-19, there has been a significant increase in the number of people affected by long-term smell and taste loss, with no effective pharmaceutical options previously available. Smell loss can also be an early indicator of neurodegenerative conditions, suggesting future applications of the intranasal spray that aims to directly restore

en

0:00

Video Technology and AI Platform for Empathetic...

Empowered Patient Podcast ·

2025/08/12

Loren Larsen, CEO and Co-Founder of Videra Health, is using AI-powered technology to improve the patient-provider connection and monitor patient health, particularly mental health, in an empathetic and conversational way. The video-based AI platform engages patients in regular check-ins to assess mental and physical conditions and detect subtle changes in behavior, tone, or language that could indicate issues like suicidal ideation or movement disorders. Data from patient encounters is also

en

20:20

Video Technology and AI Platform for Empathetic...

Empowered Patient Podcast ·

2025/08/12

Loren Larsen, CEO and Co-Founder of Videra Health, is using AI-powered technology to improve the patient-provider connection and monitor patient health, particularly mental health, in an empathetic and conversational way. The video-based AI platform engages patients in regular check-ins to assess mental and physical conditions and detect subtle changes in behavior, tone, or language that could indicate issues like suicidal ideation or movement disorders. Data from patient encounters is also

en

0:00

Advancements in Robotic Surgery Transforming Cardiac...

Empowered Patient Podcast ·

2025/08/11

David Fischel, CEO and Chairman of the Board of Stereotaxis, is advancing the ability of surgical robotics, particularly in the field of minimally invasive catheter-based procedures. Stereotaxis is developing the use of robotic technology to improve precision and accessibility in endovascular surgeries with a unique mechanism that allows surgeons to control the tip of the catheter. The adoption of surgical robotics for endovascular procedures will expand as remote access is made available and

en

20:39

Advancements in Robotic Surgery Transforming Cardiac...

Empowered Patient Podcast ·

2025/08/11

David Fischel, CEO and Chairman of the Board of Stereotaxis, is advancing the ability of surgical robotics, particularly in the field of minimally invasive catheter-based procedures. Stereotaxis is developing the use of robotic technology to improve precision and accessibility in endovascular surgeries with a unique mechanism that allows surgeons to control the tip of the catheter. The adoption of surgical robotics for endovascular procedures will expand as remote access is made available and

en

0:00

Breaking Down Data Silos to Improve Clinical Workflow...

Empowered Patient Podcast ·

2025/08/07

Craig Limoli, Co-Founder and CEO of Wellsheet, is streamling workflows for clinicians by providing better access to patient data and improving care coordination across care teams. Wellsheet is integrated into existing health records to provide a seamless experience to users and help to reduce "pajama time" for doctors by reducing the amount of end-of-the-day work needed to document patient encounters. Wellsheet uses AI and natural language processing to surface the most relevant information for

en

20:29

Breaking Down Data Silos to Improve Clinical Workflow...

Empowered Patient Podcast ·

2025/08/07

Craig Limoli, Co-Founder and CEO of Wellsheet, is streamling workflows for clinicians by providing better access to patient data and improving care coordination across care teams. Wellsheet is integrated into existing health records to provide a seamless experience to users and help to reduce "pajama time" for doctors by reducing the amount of end-of-the-day work needed to document patient encounters. Wellsheet uses AI and natural language processing to surface the most relevant information for

en

0:00

Harnessing AI to Design Antibodies and Further...

Empowered Patient Podcast ·

2025/08/06

Aron Knickerbocker, President and CEO of Aulos Bioscience, is on a mission to extend the lives of cancer patients through safer and more effective immunotherapy using AI and machine learning to accelerate drug discovery and optimization. The company's lead drug candidate is an antibody that was designed using AI to harness the power of interleukin-2 to activate the immune system against tumors. The advantages of AU-007 over previous IL-2 therapies include the ability to selectively activate

en

18:32

Harnessing AI to Design Antibodies and Further...

Empowered Patient Podcast ·

2025/08/06

Aron Knickerbocker, President and CEO of Aulos Bioscience, is on a mission to extend the lives of cancer patients through safer and more effective immunotherapy using AI and machine learning to accelerate drug discovery and optimization. The company's lead drug candidate is an antibody that was designed using AI to harness the power of interleukin-2 to activate the immune system against tumors. The advantages of AU-007 over previous IL-2 therapies include the ability to selectively activate

en

0:00

Unified AI-Powered Platform Improving Patient Access...

Empowered Patient Podcast ·

2025/08/05

Aniq Rahman, Founder and CEO of Fabric, a technology company that uses an AI-powered platform to support health systems, health plans, and employers, to streamline patient care, scheduling appointments, and receiving virtual care. The system can triage patients, route them to appropriate care, and simplify the provider workflows to improve operational efficiency, drive better patient outcomes, and reduce provider burnout. Fabric is taking an integrated approach to healthcare technology rather than

en

21:34

Unified AI-Powered Platform Improving Patient Access...

Empowered Patient Podcast ·

2025/08/05

Aniq Rahman, Founder and CEO of Fabric, a technology company that uses an AI-powered platform to support health systems, health plans, and employers, to streamline patient care, scheduling appointments, and receiving virtual care. The system can triage patients, route them to appropriate care, and simplify the provider workflows to improve operational efficiency, drive better patient outcomes, and reduce provider burnout. Fabric is taking an integrated approach to healthcare technology rather than

en

2,497 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown